Publications by authors named "Wayne Rackoff"

Claim this Profile
A
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
Matthew R Smith, Fred Saad, Simon Chowdhury, Stéphane Oudard, Boris A Hadaschik, Wayne R Rackoff

N Engl J Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegylated liposomal doxorubicin plus docetaxel significantly improves time to progression without additive cardiotoxicity compared with docetaxel monotherapy in patients with advanced breast cancer previously treated with neoadjuvant-adjuvant anthracycline therapy: results from a randomized phase III study.
Joseph A Sparano, Anatoly N Makhson, Vladimir F Semiglazov, Sergei A Tjulandin, Olga I Balashova, Wayne R Rackoff

J Clin Oncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression.
Robert Z Orlowski, Arnon Nagler, Pieter Sonneveld, Joan Bladé, Roman Hajek, Wayne Rackoff

J Clin Oncol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia.
Jean-Luc Harousseau, Jeffrey E Lancet, Josy Reiffers, Bob Lowenberg, Xavier Thomas, Wayne Rackoff

Blood· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory acute myelogenous leukemia.
Mitch Raponi, Jean-Luc Harousseau, Jeffrey E Lancet, Bob Löwenberg, Richard Stone, Wayne Rackoff

Clin Cancer Res· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early changes in CA125 after treatment with pegylated liposomal doxorubicin or topotecan do not always reflect best response in recurrent ovarian cancer patients.
Robert L Coleman, Alan Gordon, James Barter, Steven Sun, Wayne Rackoff

Oncologist· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
Timothy Cooley, David Henry, Margaret Tonda, Steven Sun, Martin O'Connell, Wayne Rackoff

Oncologist· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy.
Bassem I Razzouk, Jeffrey D Hord, Marilyn Hockenberry, Pamela S Hinds, James Feusner, Wayne R Rackoff

J Clin Oncol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unprofessional behavior among medical students.
Wayne R Rackoff

N Engl J Med· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy.
Pamela S Hinds, Marilyn Hockenberry, James Feusner, Jeffrey D Hord, Wayne Rackoff

J Support Oncol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer.
Alan N Gordon, Margaret Tonda, Steven Sun, Wayne Rackoff,

Gynecol Oncol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies.
Jorge Cortes, Maher Albitar, Deborah Thomas, Francis Giles, Razelle Kurzrock, Wayne Rackoff

Blood· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease.
Deborah Dean, Lynne Neumayr, Dana M Kelly, Samir K Ballas, Klara Kleman, Wayne R Rackoff

J Pediatr Hematol Oncol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Beverly J Lange, Bruce C Bostrom, Joel M Cherlow, Martha G Sensel, Mei K L La, Wayne Rackoff

Blood· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis